Explore evidence

6.4 %HBV prevalence was 6.4% (95% CI: 3.3–9.5%) among persons aged 45–54 years in Kenya.

Kenyahépatite Bobserved 2018published 2024PloS onePubMeddocument of 10 observations

6 %Genotype D accounted for 6% of hepatitis B virus infections in Kenya.

Kenyahépatite Bpublished 2023PLOS global public healtheurope_pmcdocument of 8 observations

13 %The seroprevalence of Hepatitis B infection among HIV infected persons was 13%.

Kenyahépatite B · VIH/sidapublished 2012The African Journal of Pharmacology and TherapeuticsOpenAlexdocument of 2 observations

3 %HBV prevalence among persons aged 15–64 years in Kenya was 3.0%.

Kenyahépatite Bobserved 2018published 2024PloS onePubMeddocument of 10 observations

8.8 %Of 859 participants who were never infected with HBV, 60 (8.8%) had anti-HBs titers >10 IU/L, indicating immunity due to vaccination.

Kenyahépatite Bpublished 2023PloS onePubMeddocument of 15 observations

5.3 %Among 208 HIV-infected ART-naïve adults in Kenya, 11 (5.3%) had occult hepatitis B virus (OBI) infection.

Kenyahépatite B · VIH/sidapublished 2021PloS onePubMeddocument of 7 observations

10.1 %The prevalence of HBsAg positivity was 10.1% among 99 male sex workers in Nairobi.

Kenyahépatite Bpublished 2020PloS onePubMeddocument of 2 observations

95.7 %Among 208 HIV-infected ART-naïve adults in Kenya, 199 (95.7%) did not report hepatitis B virus (HBV) vaccination.

Kenyahépatite B · VIH/sidapublished 2021PloS onePubMeddocument of 7 observations

4.9 %HBV prevalence by site was: Entebbe (4.9%), Kampala (4.1%), and Nairobi (0.3%).

Kenyahépatite Bpublished 2023PloS onePubMeddocument of 15 observations

28.5 %Among 1265 participants with complete data on HBsAg and HBcAb-Total, 28.5% had past HBV infection.

Kenyahépatite Bpublished 2023PloS onePubMeddocument of 15 observations

3 %The weighted national HBV prevalence was 3.0% (95% CI: 2.2–3.9%).

Kenyahépatite Bobserved 2018published 2024PloS onePubMeddocument of 10 observations

6.1 %Pooled HBV prevalence was 6.1% in the moderate-risk group.

Kenyahépatite Bpublished 2023PLOS global public healtheurope_pmcdocument of 8 observations

0.51 aorThe odds of never being HBV infected were lower among older individuals aged 25–29 years (adjusted odds ratio 0.51).

Kenyahépatite Bpublished 2023PloS onePubMeddocument of 15 observations

3 %HBV prevalence was 3.0% (95% CI: 2.1–3.9%) among HIV-negative persons in Kenya.

Kenyahépatite Bobserved 2018published 2024PloS onePubMeddocument of 10 observations

1.3 %Among 3152 participants who inject drugs in Kenya, 40 (1.3%) were HBV-positive.

Kenyahépatite Bpublished 2025The International journal on drug policyPubMeddocument of 6 observations

2.21 aorThe odds of never being HBV infected were higher among participants with informal high-risk jobs from Kampala (adjusted odds ratio 2.21) compared to those from Entebbe.

Kenyahépatite Bpublished 2023PloS onePubMeddocument of 15 observations

2.61 aorThe odds of never being HBV infected were higher among participants with informal high-risk jobs from Nairobi (adjusted odds ratio 2.61) compared to those from Entebbe.

Kenyahépatite Bpublished 2023PloS onePubMeddocument of 15 observations

258 patientsA total of 258 patients participated in the study, with 129 HIV mono-infected (controls) and 129 HIV/HBV co-infected (cases).

Kenyahépatite B · VIH/sidapublished 2021Pan African Medical JournalOpenAlexdocument of 10 observations

67.9 %Among 1265 participants with complete data on HBsAg and HBcAb-Total, 67.9% were never infected with HBV.

Kenyahépatite Bpublished 2023PloS onePubMeddocument of 15 observations

92 %Genotype A accounted for 92% of hepatitis B virus infections in Kenya.

Kenyahépatite Bpublished 2023PLOS global public healtheurope_pmcdocument of 8 observations

7.8 %The overall pooled prevalence estimate of Hepatitis B virus infection in Kenya was 7.8%.

Kenyahépatite Bpublished 2023Frontiers in public healthPubMeddocument of 6 observations

810,600 inhabitantsThe HBV infection burden was estimated at 810,600 persons aged 15–64 years in Kenya.

Kenyahépatite Bobserved 2018published 2024PloS onePubMeddocument of 10 observations

Hepatitis B coinfection was observed at similar rates in both the AFRICOS and DC Cohort samples.

Kenyahépatite Bpublished 2022PloS onePubMeddocument of 13 observations

57.2 %Among 208 HIV-infected ART-naïve adults in Kenya, 119 (57.2%) had no hepatitis B virus (HBV) markers.

Kenyahépatite B · VIH/sidapublished 2021PloS onePubMeddocument of 7 observations

10.7 %HBV prevalence was 10.7% (95% CI: 5.1–16.4%) among persons who reported no formal education in Kenya.

Kenyahépatite Bobserved 2018published 2024PloS onePubMeddocument of 10 observations